HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Labeling of low-density lipoproteins using the 18F-labeled thiol-reactive reagent N-[6-(4-[18F]fluorobenzylidene)aminooxyhexyl]maleimide.

Abstract
The novel thiol-group-selective bifunctional 18F-labeling agent N-[6-(4-[18F]fluoro-benzylidene)aminooxyhexyl]maleimide ([18F]FBAM) has been developed. The bifunctional labeling precursor N-(6-aminoxyhexyl)maleimide containing a thiol-reactive maleimide group and a carbonyl-group-reactive aminooxy group was prepared in only three steps in a total chemical yield of 59%. Subsequent radiolabeling with 4-[18F]fluorobenzaldehyde gave the bifunctional 18F-labeling agent [18F]FBAM in a radiochemical yield of 29%. In a typical experiment, 3.88 GBq of [18F]fluoride could be converted into 723 MBq of [18F]FBAM within 69 min. Conjugation of [18F]FBAM with thiol groups was exemplified with the cysteine-containing tripeptide glutathione and with various apolipoproteins of human low-density lipoprotein (LDL) subfractions. The latter was evaluated with respect to the uptake of [18F]FBAM-LDL subfractions in human hepatoma cells (HepG2) in vitro. In vivo biodistribution studies in rats revealed high stability for [18F]FBAM-LDL subfractions. Moreover, the metabolic fate of [18F]FBAM-LDL subfractions in vivo was delineated by dynamic positron emission tomography studies using a dedicated small animal tomograph. Data were compared to former studies that used the NH2-reactive 18F-labeling agent N-succinimidyl-4-[18F]fluorobenzoate. The compound [18F]FBAM can be considered as an excellent prosthetic group for the selective and mild 18F labeling of thiol-group-containing biomolecules suitable for subsequent investigations in vitro and in vivo.
AuthorsMathias Berndt, Jens Pietzsch, Frank Wuest
JournalNuclear medicine and biology (Nucl Med Biol) Vol. 34 Issue 1 Pg. 5-15 (Jan 2007) ISSN: 0969-8051 [Print] United States
PMID17210457 (Publication Type: Journal Article)
Chemical References
  • Lipoproteins, LDL
  • Maleimides
  • N-(6-(4-fluorobenzylidene)aminooxyhexyl)maleimide
  • Radiopharmaceuticals
Topics
  • Animals
  • Carcinoma, Hepatocellular (diagnostic imaging, metabolism)
  • Cell Line, Tumor
  • Humans
  • Isotope Labeling (methods)
  • Lipoproteins, LDL (chemistry, pharmacokinetics)
  • Male
  • Maleimides (chemistry, pharmacokinetics)
  • Metabolic Clearance Rate
  • Organ Specificity
  • Radionuclide Imaging
  • Radiopharmaceuticals (chemical synthesis, pharmacokinetics)
  • Rats
  • Rats, Wistar
  • Tissue Distribution

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: